← Biofrontera Inc.

Annual Trend FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $18.8m $24.1m $28.5m $34.1m $37.3m $41.7m
Revenues, related party — — $133k $66k $18k —
Total revenues, net $18.8m $24.1m $28.7m $34.1m $37.3m $41.7m
Cost of Revenue $8.0m $10.2m $12.1m $17.4m $18.6m $11.0m
Reconciled Cost Of Revenue — — $15.2m $17.4m $18.6m $11.0m
Gross Profit (derived) $10.8m $13.9m $13.5m $16.6m $18.7m $30.7m
Research And Development — — $0 $77k $2.1m $3.7m
Selling, general and administrative, related party $411k $697k $733k $152k $42k $619k
Operating Expenses $28.5m $49.3m $47.3m $56.7m $54.5m $53.1m
Total operating expenses $28.5m $49.3m $47.3m $56.7m $54.5m $53.1m
Operating Income (Loss) ($9.6m) ($25.2m) ($18.6m) ($22.7m) ($17.2m) ($11.3m)
Additional Financial Items
Product revenues, net — $24.0m $28.5m $34.0m $37.3m $41.7m
Amortization of Intangible Assets $418k $418k $418k $418k $329k —
Equity Securities, FV-NI, Realized Gain (Loss) — — — $7.2m $98k —
Gain (Loss) on Investments — — $1.7m ($7.4m) ($14k) $2k
Gain (Loss) Related to Litigation Settlement — — — $7.4m — —
Income (Loss) from Equity Method Investments — — $1.7m ($7.4m) ($14k) $2k
Interest Income, Other — — $10k $132k — —
Loss from operations ($9.6m) ($25.2m) ($18.6m) ($22.7m) ($17.2m) ($11.3m)
Change in fair value of warrant liabilities — ($12.8m) $16.4m $6.5m $1.7m $899k
Loss before income taxes ($10.9m) ($37.7m) ($608k) ($20.1m) ($17.7m) ($10.5m)
Net loss ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Diluted EPS — — ($0.48) ($13.02) ($3.22) ($0.90)
Diluted NI Availto Com Stockholders ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Gain On Sale Of Security — — $18.1m ($4.4m) $1.7m $901k
Interest Income — $16k $175k $132k $71k —
Interest Income Non Operating — $16k $175k $132k $71k —
Net Income From Continuing And Discontinued Operation ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Net Income From Continuing Operation Net Minority Interest ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Net Interest Income — — ($203k) ($560k) ($2.0m) ($452k)
Normalized EBITDA — — ($21.0m) ($21.5m) ($15.9m) ($10.1m)
Normalized Income — — ($17.9m) ($22.5m) ($18.8m) ($11.2m)
Other Gand A — $37.2m $35.9m $39.1m — —
Other Special Charges — — — ($7.5m) $316k —
Reconciled Depreciation — — $1.2m $1.1m $1.1m $868k
Restructuring And Mergern Acquisition — ($650k) ($3.8m) $100k $0 —
Selling General And Administration — — $35.9m $39.1m $33.8m $38.4m
Special Income Charges — — $3.8m $7.4m ($316k) $0
Tax Effect Of Unusual Items — — $4.6m $635k $284k $189k
Tax Provision $64k $56k $32k $14k $22k $25k
Tax Rate For Calcs — — $0 $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ($10.9m) ($37.7m) ($608k) ($20.1m) ($17.7m) ($10.5m)
Total Unusual Items — — $21.9m $3.0m $1.4m $901k
Total Unusual Items Excluding Goodwill — — $21.9m $3.0m $1.4m $901k
Pre-Tax Income ($10.9m) ($37.7m) ($608k) ($20.1m) ($17.7m) ($10.5m)
Net Income Continuous Operations ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Net Income (Loss) Attributable to Parent ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Net Income (Loss) Available to Common Stockholders, Basic ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Net Income Including Noncontrolling Interests ($11.0m) ($37.7m) ($640k) ($20.1m) ($17.8m) ($10.5m)
Earnings Per Share, Basic — ($4.28) ($0.61) ($13.02) ($3.22) ($1.04)
Earnings Per Share, Diluted — — — ($13.02) ($3.22) ($1.04)
Basic — $8,808,233.00 $21,139,765.00 $1,546,297.00 $5,516,334.00 $10,171,921.00
Diluted — — $1,056,988.00 $1,546,297.00 $5,516,334.00 $10,171,921.00
Weighted Average Number of Shares Outstanding, Basic — — 1.1m 1.5m 5.5m 10.2m
Basic Average Shares — — $1.3m $1.5m $5.5m $11.6m
Diluted Average Shares — — $1.3m $1.5m $5.5m $11.6m
Weighted Average Number of Shares Outstanding, Diluted — — — 1.5m 5.5m 10.2m
Research and Development Expense — — — $77k $2.1m $3.7m
General and Administrative Expense — $37.2m $35.9m $39.1m $16.3m $22.9m
Selling, General and Administrative Expense $17.7m $36.5m $35.1m $39.0m $33.8m $37.8m
Other Nonoperating Income (Expense) $1.6m $689k $33k ($75k) $158k $388k
Costs and Expenses — — — — $54.5m $53.1m
Restructuring Costs $1.1m $800k $0 — — —
Non-Operating Income (Expense) $1.6m $689k $33k ($75k) $158k $388k
Interest Expense $2.9m $344k $195k $220k ($2.0m) ($452k)
Interest Expense, Debt — $2k — — — —
Income tax expenses $64k $56k $32k $14k $22k $25k
Interest Expense Non Operating — — $370k $600k $2.0m $452k
Net Non Operating Interest Income Expense — — ($203k) ($560k) ($2.0m) ($452k)
Operating Expense — — $35.9m $39.2m $35.9m $42.1m
Other Income Expense — — $22.0m $3.0m $1.5m $1.3m
Other Non Operating Income Expenses — — $69k ($3k) $158k $388k
Interest Income (Expense), Net ($2.9m) ($344k) ($195k) ($468k) — —
Interest Income (Expense), Nonoperating, Net — — — — ($2.0m) ($452k)
Total other income (expense) ($1.3m) ($12.5m) $18.0m $2.6m ($527k) $837k
Income Tax Expense (Benefit) $64k $56k $32k $14k $22k $25k
Total Expenses — — $51.1m $56.6m $54.5m $53.1m
Total Other Finance Cost — — $8k $92k $41k —

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.